Basic Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Jun 28, 2015; 21(24): 7457-7467
Published online Jun 28, 2015. doi: 10.3748/wjg.v21.i24.7457
Table 1 Clinicopathological characteristics for 100 patients with colon carcinoma
CharacteristicNumber of patientsPercentage
Sex
Male5454
Female4646
Age (yr)
< 606161
≥ 603939
Tumor location
Right3939
Transverse1010
Left colon5151
Depth1
< 5 mm7272
≥ 5 mm2828
Maximum diameter of tumor (cm)
≥ 1.0 and < 5.06767
≥ 5.03333
Tumor differentiation
Well1919
Moderate5353
Poor2121
Unknown77
Lymph node metastasis
02323
1-43232
≥ 54545
Venous vessel invasion
Absent4242
Present5858
Tumor margin
Expanding8181
Infiltrating1919
Table 2 Effects of both integrin αvβ6 and matrix metalloproteinase-9 expression in100 cases of colon carcinoma
VariableImmunoreactivity of tumor samples (n)
PositiveLow expressionHigh expression
ανβ6Deep section of tumor382771.1%1128.9%
Superficial section of tumor381026.3%2873.7%1
MMP-9Deep section of tumor683551.5%3348.5%
Superficial section of tumor681623.5%5276.5%1
Table 3 Five year survival estimates for 100 patients with colon cancer
GroupsNegative/positivenMedian survival (mo) and 95%CI5-yr survival rate (%) and 95%CI
αvβ6Negative6245.948 (40.575-51.320)0.585 (0.452-0.718)
Positive3836.114 (28.501-43.728)0.402 (0.220-0.584)1
MMP-9Negative3244.071 (36.812-51.330)0.570 (0.392-0.748)
Positive6841.686 (36.040-47.331)0.485 (0.344-0.626)2